Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy.

Published byDarrell York Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy."— Presentation transcript:

1 Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4): doi: /rpd/ncm295 Radiat Prot Dosimetry | © The Author Published by Oxford University Press. All rights reserved. For Permissions, please

2 Figure 2. Activity found in nose swabs and early faecal excretion for each subject at the reprocessing plant. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4): doi: /rpd/ncm295 Radiat Prot Dosimetry | © The Author Published by Oxford University Press. All rights reserved. For Permissions, please

3 Figure 3. Activity found in nose swabs and early faecal excretion for each subject at the other facilities. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4): doi: /rpd/ncm295 Radiat Prot Dosimetry | © The Author Published by Oxford University Press. All rights reserved. For Permissions, please

4 Figure 4. Cumulative probability of the activity ratio of nose swabs to early faeces.
From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4): doi: /rpd/ncm295 Radiat Prot Dosimetry | © The Author Published by Oxford University Press. All rights reserved. For Permissions, please

5 Figure 5. Relationship between activity of nose swabs and resulting effective dose for each of the subject (Figure 1–3). Parameter values (α, β) are used in case of <sup>241</sup>Pu or/and <sup>241</sup>Am in early faeces being not available. From: Practical action levels for chelation therapy in plutonium inhalation using nose swab Radiat Prot Dosimetry. 2007;127(1-4): doi: /rpd/ncm295 Radiat Prot Dosimetry | © The Author Published by Oxford University Press. All rights reserved. For Permissions, please

Download ppt "Figure 1. Activity found in nose swabs and early faecal excretion for each subject at the MOX facilities. From: Practical action levels for chelation therapy."

Similar presentations

Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L.

Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L.
Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11):779-788 October 17, 2005 © The Author 2005. Published by Oxford University.

Cancer cachexia by J.N. Gordon, S.R. Green, and P.M. Goggin QJM Volume 98(11): October 17, 2005 © The Author Published by Oxford University.
Disorders of cognitive and affective development in cerebellar malformations by Alessandro Tavano, Rita Grasso, Chiara Gagliardi, Fabio Triulzi, Nereo.

Disorders of cognitive and affective development in cerebellar malformations by Alessandro Tavano, Rita Grasso, Chiara Gagliardi, Fabio Triulzi, Nereo.
Fig. 1. Flow diagram of study participants and outcomes.

Fig. 1. Flow diagram of study participants and outcomes.
From: An open day in the metric space

From: An open day in the metric space
Figure 4. NMDAR subunit protein levels in control and schizophrenic subjects. Scatter plots showing (A) NR1, (B) NR3A, and (C) NR3A/NR1. Small circles.

Figure 4. NMDAR subunit protein levels in control and schizophrenic subjects. Scatter plots showing (A) NR1, (B) NR3A, and (C) NR3A/NR1. Small circles.
Figure 3. Day 2 cell symmetry

Figure 3. Day 2 cell symmetry
Figure 2 Effects of political reforms on tariff reduction and political approval rating. From: TPP negotiations and political economy reforms in Japan’s.

Figure 2 Effects of political reforms on tariff reduction and political approval rating. From: TPP negotiations and political economy reforms in Japan’s.
Fig. 1. Top-level classes of SBRML-OM.

Fig. 1. Top-level classes of SBRML-OM.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Figure 3. Count rates at the eight measurement locations at ZWILAG in the vicinity of a cask filled with spent fuel (left column) and a cask containing.

Figure 3. Count rates at the eight measurement locations at ZWILAG in the vicinity of a cask filled with spent fuel (left column) and a cask containing.
From: North Korea's foreign economic relations

From: North Korea's foreign economic relations
Figure 2. Dose distribution function for thyroid cancer cases and for healthy members of the cohort for adults (18 y of age and older at the time of the.

Figure 2. Dose distribution function for thyroid cancer cases and for healthy members of the cohort for adults (18 y of age and older at the time of the.
Figure 3. Average response time by signal-to-noise ratio (SNR), group, and condition. Error bars represent standard error. Response time was measured as.

Figure 3. Average response time by signal-to-noise ratio (SNR), group, and condition. Error bars represent standard error. Response time was measured as.
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1 Individual Lifted from Group Photograph

Figure 1 Individual Lifted from Group Photograph
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Figure 4. p-Values from Larsson et al

Figure 4. p-Values from Larsson et al
Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.

Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.
Figure 2 Distribution of Annual Household Income for Jordan Overall, Camp Refugees, and Camp Poor From: A Profile of Poverty for Palestinian Refugees in.

Figure 2 Distribution of Annual Household Income for Jordan Overall, Camp Refugees, and Camp Poor From: A Profile of Poverty for Palestinian Refugees in.

Similar presentations

Ads by Google